Figure 2 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
The role of LABA/LAMA and add-on therapies in the management of... | Download Scientific Diagram
Approved fixed-dose combinations of LABAs and LAMAs for COPD treatment | Download Scientific Diagram
Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease ( COPD): Boon or Bane? | American Board of Family Medicine
COPD Inhalers - Easy to Use Reference Tool - CommPharm Consulting
Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect
Terapia con LAMA/LABA nelle GOLD 2017 per la BPCO • NCF
Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect
Frontiers | Single Inhaler LABA/LAMA for COPD
Long-acting maintenance pharmacotherapy in chronic obstructive pulmonary disease - ScienceDirect
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología
Chronic obstructive pulmonary disease (COPD) - Management Approach | BMJ Best Practice
Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
LAMA/LABA Fixed-dose Combo May Be Superior for COPD Therapy | RT
A new alphabet for COPD care | European Respiratory Society
Frontiers | Single Inhaler LABA/LAMA for COPD
Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients? | Respiratory Research | Full Text
In Depth | Anoro Ellipta: first LABA/LAMA combination inhaler for COPD
Long-Acting Dual Bronchodilators - LAMA/LABA Combo ... | GrepMed
LAMA/LABA therapy reduced risk for COPD exacerbation, pneumonia hospitalization
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework | Respiratory Research | Full Text
Effect of adding a LABA to a LAMA on FEV 1 in patients with COPD | Download Scientific Diagram
Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box | European Respiratory Society
Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
American College of Chest Physicians - In a real-world setting, LAMA-LABA-ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone
